-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$28.6758.75% Upside
Kura Oncology, Inc. Frequently Asked Questions
-
What analysts cover Kura Oncology, Inc.?
Kura Oncology, Inc. has been rated by research analysts at H.C. Wainwright, Stifel Nicolaus, Mizuho Securities in the past 90 days.